Analyst Research

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Australian Patent Office Grants Sanofi SA Patent for Substituted N-phenyl-pyrrolidinylmethylpyrrolidine Amides -Australian Government News


Monday, 8 Jul 2013 08:00pm EDT 

Australian Government News reported that Australian Patent Office has granted patent (2008312636) filed by Sanofi SA on October 14, 2008, for Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators. The patent is effective from October 14, 2008, till October 14, 2028. 

Company Quote

86.5
-0.68 -0.78%
11:36am EDT